Ward 8E is a 21 bed Haematology/Transplant Unit at Royal North Shore Hospital - ranked the 3rd best hospital in Australia in 2022.
Employment Type: Permanent Part Time
Position Classification: Registered Nurse
Remuneration: $35.33 - $49.60 per hour
Hours Per Week: 28
Requisition ID: REQ463986
.
Where you'll be working
Royal North Shore Hospital
You will care for patients requiring chemotherapy, Bone Marrow transplantation (including Auto, Allogenic and MUD transplants), radiotherapy, blood products among other intensive interventions required when dealing with Haematological disorders. Staff are supported by the NUM, CNE and CNC based on the ward and through the hospital.
What you'll be doing
The NSLHD Nursing and Midwifery Workforce will be compassionate, competent, confident, contemporary, capable and committed to leading person-centred health care.
Assess, plan, implement and evaluate nursing care in collaboration with individual/s and the greater health care team to achieve quality patient care outcome.
People of Aboriginal and/or Torres Strait Islander background encouraged to apply.
Candidates will need to meet the following criteria:
- Registered Nurse - Division 1 with Australian Health Practitioner Regulation Agency (AHPRA).
- Current experience in an acute hospital environment, including examples of current clinical knowledge and critical thinking.
- Demonstrated effective interpersonal, verbal and written communication skills.
- Ability to work effectively within a multi-disciplinary team.
1) Click here for the
2) Find out more about for this position
For role related queries or questions contact Katrina Moulden on Katrina.Moulden@health.nsw.gov.au
This is a NSW Health Category A position which requires immunisation and screening for certain diseases including COVID-19. The full list of requirements are outlined in the You will be required to complete the and during the recruitment process. Please upload this with your application along with any other vaccination evidence that you may have.
NSW Health is committed to implementing the .
Applications Close: 29 February 2024